Anti-cancer immunotherapy: breakthroughs and future strategies
Author:
Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy
Link
http://link.springer.com/article/10.1007/s00281-018-0711-z/fulltext.html
Reference12 articles.
1. Hasselbalch HC, Holmström MO (2018) Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms. Minimal residual disease and cure ? Semin Immunopathol 2018. https://doi.org/10.1007/s00281-018-0700-2
2. Schmidt EV (2018) Developing combination strategies using PD-1 checkpoint inhibitors to treat cancer. Semin Immunopathol. https://doi.org/10.1007/s00281-018-0714-9
3. Draghi A, Chamberlain CA, Furness A, Donia M (2018) Acquired resistance to cancer immunotherapy. Semin Immunopathol. https://doi.org/10.1007/s00281-018-0692-y
4. Muller A, Manfredi MG, Zakharia Y, Prendergast GC (2018) Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond. Semin Immunopathol. https://doi.org/10.1007/s00281-018-0702-0
5. Met Ö, Jensen KM, Chamberlain CA, Donia M, Svane IM (2018) Principles of adoptive T-cell therapy in cancer. Semin Immunopathol. https://doi.org/10.1007/s00281-018-0703-z
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. PRMT3‐Mediated Arginine Methylation of METTL14 Promotes Malignant Progression and Treatment Resistance in Endometrial Carcinoma;Advanced Science;2023-11-16
2. Spherical Ball-Shaped Intrauterine Device Long-Acting Reversible Contraception: Post-marketing Pharmacovigilance Assessment;EMJ Reproductive Health;2023-07-28
3. Deciphering the Relationship between SARS-CoV-2 and Cancer;International Journal of Molecular Sciences;2023-04-25
4. Oncolytic Adenoviruses Armed with Co-Stimulatory Molecules for Cancer Treatment;Cancers;2023-03-23
5. A novel therapeutic vaccine based on graphene oxide nanocomposite for tumor immunotherapy;Chinese Chemical Letters;2022-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3